Neuro-Care Sp. Z.o.o. Sp
- Address
- Neuro-Care Sp. Z.o.o. Sp, Komandytowa ul. Szpitalna 6, 41-100 Siemianowice Śląskie, Poland
Neuro-Care Sp. Z.o.o. Sp
Neuro-Care Sp. Z.o.o. Sp is a specialized clinical research facility dedicated to advancing treatment options for complex neurological disorders. The center demonstrates particular expertise in conducting Phase 3 clinical trials focused on autonomic nervous system dysfunction and neurodegenerative conditions affecting cardiovascular regulation.
- Neurogenic Orthostatic Hypotension (nOH) in Multiple System Atrophy patients
- Novel therapeutic interventions for autonomic dysfunction
- Long-term efficacy and durability studies in neurodegenerative diseases
The research center specializes in evaluating innovative pharmacological treatments for symptomatic neurogenic orthostatic hypotension, a debilitating condition affecting patients with Multiple System Atrophy (MSA). Their clinical trial capabilities include sophisticated study designs incorporating both open-label and randomized withdrawal methodologies to assess both immediate efficacy and long-term treatment durability using validated assessment tools such as the OHSA composite score.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Neuro-Care Sp. Z.o.o. Sp
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Durability of Ampreloxetine in Treating Symptomatic Neurogenic Orthostatic Hypotension in Multiple System Atrophy: A Phase 3 Study | Theravance Biopharma Ireland Limited | Phase III | Not Recruiting | Oct 2023 | Jun 2026 |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ampreloxetine | 1 | Unknown | 2023-10-25 | 2023-10-25 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.